New Zealand Stock News

Fisher & Paykel Healthcare has already reported half-year 2025 results showing sales of NZ$1,088.5 million and net income of NZ$213.0 million, alongside higher basic earnings per share and an increased interim dividend. The company also raised its full-year revenue and net profit guidance, signaling management confidence that recent operational momentum can continue. Next, we’ll explore how the upgraded full-year earnings guidance may influence Fisher & Paykel Healthcare’s existing...

Green Cross Health Limited ( NZSE:GXH ) will increase its dividend on the 18th of December to NZ$0.0353, which is 20...

Tower Limited ( NZSE:TWR ) came out with its full-year results last week, and we wanted to see how the business is...

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...

It looks like Green Cross Health Limited ( NZSE:GXH ) is about to go ex-dividend in the next 3 days. The ex-dividend...

a2 Milk (NZSE:ATM) has secured approvals from New Zealand and Chinese authorities for its plan to transition China label infant formula registrations to a2MC branding. The company expects to make the final regulatory submission next month, which will support future product launches. See our latest analysis for a2 Milk. Momentum has been building for a2 Milk, with the latest regulatory wins in China and upbeat earnings guidance helping to extend a rally that has seen a 73.34% year-to-date...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

The recent earnings posted by Oceania Healthcare Limited ( NZSE:OCA ) were solid, but the stock didn't move as much as...

Last week saw the newest half-year earnings release from Fisher & Paykel Healthcare Corporation Limited ( NZSE:FPH...

Rakon (NZSE:RAK) just posted its H1 2026 results, reporting revenue of 62.004 million NZD and basic EPS of 0.0196 NZD. Looking back, the company has seen revenue go from 41.657 million NZD in H1 2025 to 66.756 million NZD in H2 2024 before reaching the latest figure. EPS moved from -0.046 NZD up to 0.018276 NZD, then to the current 0.0196 NZD. With these numbers out, it is clear margin performance continues to shape investor discussions around the business. See our full analysis for...

One thing we could say about the analysts on Pacific Edge Limited ( NZSE:PEB ) - they aren't optimistic, having just...

Ryman Healthcare (NZSE:RYM) has just reported H1 2026 financial results, posting total revenue of $806.7 million NZD and basic EPS of -0.64 NZD for the trailing twelve months. Historically, the company has seen revenue climb from $355.2 million NZD in H2 2024 to $394.0 million NZD by H2 2025. Basic EPS over recent halves ranged from -0.72 NZD to 0.14 NZD. Margins continue to face pressure as profitability remains elusive, making this an essential set of numbers for investors to digest. See...

Stride Property Group (NZSE:SPG) has just reported H1 2026 results, with revenue coming in at NZ$136.2 million and basic EPS at NZ$0.081952 for the trailing twelve months. Historically, the company saw revenue rise from NZ$53.4 million in H2 2024 to NZ$76.1 million in H2 2025. EPS moved from -NZ$0.010129 to NZ$0.005711 over that span. Margins held steady, giving investors a clear snapshot into the REIT's operational results. See our full analysis for Stride Property Group. Now it’s time to...

The a2 Milk Company recently received approvals from New Zealand’s Ministry for Primary Industries and China Customs to progress China label infant milk formula registrations toward a2MC branded products, marking a key regulatory milestone. This regulatory development streamlines a2 Milk's pathway for expanding its branded product offerings in China, while the company also provided guidance for low double-digit percentage growth in FY26. We’ll now explore how this regulatory milestone in...

Earlier this month, Infratil reported its half-year earnings for the period ended September 30, 2025, highlighting revenue growth to NZ$1.99 billion, a return to net profit of NZ$605.7 million, and an increased interim dividend of NZ$0.08044 per share. This turnaround from a net loss a year earlier not only reflects improved business performance but also a boost to shareholder returns through a higher dividend payout. We'll now examine how this substantial return to profitability may shape...

The board of Turners Automotive Group Limited ( NZSE:TRA ) has announced that it will be paying its dividend of...

Key Insights Significant control over Fletcher Building by individual investors implies that the general public has...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Spark New Zealand fair value estimate is NZ$2.98 Spark New...

My Food Bag Group Limited ( NZSE:MFB ) has announced that it will pay a dividend of NZ$0.0088 per share on the 15th of...

Napier Port Holdings Limited's ( NZSE:NPH ) dividend will be increasing from last year's payment of the same period to...

Global markets have been under pressure recently, with AI concerns weighing heavily on investor sentiment and leading to declines across major indices. Despite this, opportunities still exist for discerning investors, particularly in the realm of penny stocks—an investment area that remains relevant despite its somewhat outdated label. These stocks often represent smaller or newer companies and can offer growth potential at lower price points when backed by strong financial health.

Despite an already strong run, Sanford Limited ( NZSE:SAN ) shares have been powering on, with a gain of 26% in the...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

Third Age Health Services Limited ( NZSE:TAH ) shareholders have had their patience rewarded with a 26% share price...